C752
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C752, covering 2025-02-18 to 2025-02-18. Get the full timeline:
Most recent: Clinical Trial Update: C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma [Phase 1]